{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:20:44Z","timestamp":1791868844020,"version":"4.3.4"},"reference-count":112,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"am","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.fjurol.2024.102736","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T03:59:44Z","timestamp":1732247984000},"page":"102736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["French AFU Cancer Committee Guidelines\u2013Update 2024\u20132026: Penile cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Paul","family":"Neuville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agate","family":"Escoffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Henri","family":"Savoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Fl\u00e9chon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Camparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Murez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fjurol.2024.102736_bib0520","series-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018 - Volume 1: Tumeurs solides","author":"Defossez","year":"2019"},{"key":"10.1016\/j.fjurol.2024.102736_bib0525","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canep.2017.08.014","article-title":"Long-term trends in incidence and survival of penile cancer in France","volume":"50","author":"Daubisse-Marliac","year":"2017","journal-title":"Can Epidemiol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0530","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.annpat.2021.03.002","article-title":"[Lesions of the penis, the anatomy, epidemiology and carcinogenesis]","volume":"42","author":"Comp\u00e9rat","year":"2022","journal-title":"Ann Pathol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0535","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MOU.0000000000000581","article-title":"Penile cancer epidemiology and risk factors: a contemporary review","volume":"29","author":"Douglawi","year":"2019","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0540","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ijc.21961","article-title":"Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival","volume":"119","author":"Lont","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fjurol.2024.102736_bib0545","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/A:1011266405062","article-title":"Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States)","volume":"12","author":"Tsen","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fjurol.2024.102736_bib0550","series-title":"Synth\u00e8se de la recommandation vaccinale: vaccination contre les papillomavirus chez les gar\u00e7ons","year":"2019"},{"key":"10.1016\/j.fjurol.2024.102736_bib0555","first-page":"1","article-title":"The clinical complexity of penile cancer: current clinical-epidemiological data from the database of the free state of Saxony\/Germany","author":"Boehm","year":"2021","journal-title":"Urol Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0560","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1464-410X.2003.04119.x","article-title":"A comparison of physical examination and imaging in determining the extent of primary penile carcinoma","volume":"91","author":"Lont","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0565","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.urology.2016.01.003","article-title":"Role of Penile Doppler US in the preoperative assessment of penile squamous cell carcinoma patients: results from a large prospective Multicenter European Study","volume":"90","author":"Bozzini","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102736_bib0570","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/jmri.27060","article-title":"Role of MRI in staging of penile cancer","volume":"51","author":"Krishna","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.fjurol.2024.102736_bib0575","first-page":"1","article-title":"Diagnostic accuracy of MRI in local staging (T Category) of penile cancer and the value of artificial erection: a systematic review and meta-analysis","author":"Krishna","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102736_bib0580","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1259\/bjr\/63301362","article-title":"MRI of the penis","volume":"85Spec","author":"Kirkham","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0585","first-page":"e56016","article-title":"Does MRI have a role in the preoperative staging of penile cancer?","volume":"16","author":"Iqbal","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.fjurol.2024.102736_bib0590","doi-asserted-by":"crossref","first-page":"100478","DOI":"10.1016\/j.ejro.2023.100478","article-title":"Multi-parametric MRI without artificial erection for preoperative assessment of primary penile carcinoma: A pilot study on the correlation between imaging and histopathological findings","volume":"10","author":"Switlyk","year":"2023","journal-title":"Eur J Radiol Open"},{"key":"10.1016\/j.fjurol.2024.102736_bib0595","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/his.14824","article-title":"WHO 2022 classification of penile and scrotal cancers: updates and evolution","volume":"82","author":"Menon","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.fjurol.2024.102736_bib0600","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/039463201302600305","article-title":"P16INK4A immunohistochemistry for detection of human papilloma virus-associated penile squamous cell carcinoma is superior to in-situ hybridization","volume":"26","author":"Aumayr","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0605","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","article-title":"European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update","volume":"83","author":"Brouwer","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0610","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/S1166-7087(20)30753-3","article-title":"[French ccAFU guidelines - update 2020-2022: penile cancer]","volume":"30","author":"Savoie","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0615","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.fjurol.2024.102736_bib0620","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00345-008-0315-7","article-title":"The role of pathologic prognostic factors in squamous cell carcinoma of the penis","volume":"27","author":"Cubilla","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0625","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5858\/arpa.2019-0544-RA","article-title":"Updates in staging and reporting of genitourinary malignancies","volume":"144","author":"Cornejo","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.fjurol.2024.102736_bib0630","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/his.14575","article-title":"A comparative study of AJCC and the modified staging system in pT2\/pT3 penile squamous cell carcinoma-a validation on an external data set","volume":"80","author":"Sali","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.fjurol.2024.102736_bib0635","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/PAS.0b013e31819d17eb","article-title":"The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma","volume":"33","author":"Chaux","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0640","doi-asserted-by":"crossref","first-page":"159.e7","DOI":"10.1016\/j.urolonc.2017.12.001","article-title":"Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: a propensity-score matched analysis","volume":"36","author":"Woldu","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0645","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.ju.0000154565.37397.4d","article-title":"Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases","volume":"173","author":"Kroon","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0650","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrurol.2017.47","article-title":"Contemporary management of patients with penile cancer and lymph node metastasis","volume":"14","author":"Leone","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0655","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcu.20420","article-title":"Sonography: an underutilized diagnostic tool in the assessment of metastatic groin nodes","volume":"36","author":"Krishna","year":"2008","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.fjurol.2024.102736_bib0660","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000112462","article-title":"Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet's node, and disease burden of inguinal lymph nodes","volume":"31","author":"Zhu","year":"2008","journal-title":"Onkologie"},{"key":"10.1016\/j.fjurol.2024.102736_bib0665","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jmri.25339","article-title":"Incremental value of MRI for preoperative penile cancer staging","volume":"45","author":"Lucchesi","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.fjurol.2024.102736_bib0670","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.euf.2021.02.012","article-title":"F-18 fluorodeoxyglucose positron emission tomography with computed tomography has high diagnostic value for pelvic and distant staging in patients with high-risk penile carcinoma","volume":"8","author":"Ottenhof","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102736_bib0675","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/RLU.0000000000004081","article-title":"Diagnostic performance of 18F-FDG PET\/CT for lymph node staging in penile cancer","volume":"47","author":"Lee","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.fjurol.2024.102736_bib0680","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.juro.2011.10.033","article-title":"Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis","volume":"187","author":"Souillac","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0685","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06159.x","article-title":"Fine-needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma","volume":"97","author":"Saisorn","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0690","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2020.09.007","article-title":"Hybrid indocyanine Green-99mTc-nanocolloid for single-photon emission computed tomography and combined radio- and fluorescence-guided sentinel node biopsy in penile cancer: results of 740 inguinal basins assessed at a single institution","volume":"78","author":"Dell\u2019Oglio","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0695","doi-asserted-by":"crossref","DOI":"10.1111\/bju.15700","article-title":"High diagnostic accuracy of inguinal ultrasonography and fine-needle aspiration followed by dynamic sentinel lymph node biopsy in men with impalpable and palpable inguinal lymph nodes","author":"Lee","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0700","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.euo.2022.09.004","article-title":"Sentinel node identification with hybrid tracer-guided and conventional dynamic sentinel node biopsy in penile cancer: a prospective study in 130 patients from the two national referral centres in Sweden","volume":"5","author":"Torbrand","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0705","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00345-015-1577-5","article-title":"Feasibility of performing dynamic sentinel lymph node biopsy as a delayed procedure in penile cancer","volume":"34","author":"Omorphos","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0710","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/bju.13680","article-title":"Management of non-visualization following dynamic sentinel lymph node biopsy for squamous cell carcinoma of the penis","volume":"119","author":"Sahdev","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0715","doi-asserted-by":"crossref","first-page":"210.e1","DOI":"10.1016\/j.urolonc.2023.02.001","article-title":"Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis","volume":"41","author":"Nazzani","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0720","doi-asserted-by":"crossref","first-page":"675565","DOI":"10.3389\/fonc.2021.675565","article-title":"Development and validation of a Nomogram for the prediction of inguinal lymph node metastasis extranodal extension in penile cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0725","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/09546634.2020.1800574","article-title":"The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature","volume":"33","author":"Kravvas","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.fjurol.2024.102736_bib0730","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jdv.16017","article-title":"European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas","volume":"33","author":"Morton","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0735","doi-asserted-by":"crossref","first-page":"803","DOI":"10.21037\/tau.2017.06.24","article-title":"Topical Therapy for non-invasive penile cancer (Tis)-updated results and toxicity","volume":"6","author":"Manjunath","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0740","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1464-410X.2009.09087.x","article-title":"Glans resection and plastic repair","volume":"105","author":"Bracka","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0745","series-title":"EAU Guidelines on Penile Cancer","author":"Hakenberg","year":"2022"},{"key":"10.1016\/j.fjurol.2024.102736_bib0750","article-title":"Radiotherapy for penile cancers","author":"Escande","year":"2021","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.fjurol.2024.102736_bib0755","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brachy.2013.01.167","article-title":"American Brachytherapy Society-Groupe Europ\u00e9en de Curieth\u00e9rapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy","volume":"12","author":"Crook","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.fjurol.2024.102736_bib0760","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.euf.2018.02.002","article-title":"Surgical and oncological outcomes in patients after vascularised flap reconstruction for locoregionally advanced penile cancer","volume":"5","author":"Ottenhof","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102736_bib0765","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.eururo.2009.02.021","article-title":"Lymphadenectomy in the surgical management of penile cancer","volume":"55","author":"Protzel","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0770","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2013.02.037","article-title":"Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis","volume":"64","author":"Stuiver","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0775","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00268-022-06882-6","article-title":"Assessment and reporting of perioperative adverse events and complications in patients undergoing inguinal lymphadenectomy for melanoma, vulvar cancer, and penile cancer: a systematic review and meta-analysis","volume":"47","author":"Cacciamani","year":"2023","journal-title":"World J Surg"},{"key":"10.1016\/j.fjurol.2024.102736_bib0780","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bjps.2012.09.030","article-title":"Inguinal lymph node dissection: epidermal vacuum therapy for prevention of wound complications","volume":"66","author":"Tauber","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.fjurol.2024.102736_bib0785","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2006.10.060","article-title":"Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival","volume":"177","author":"Lont","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0790","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00345-013-1024-4","article-title":"The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection","volume":"31","author":"Liu","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0795","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/bju.15309","article-title":"Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis","volume":"128","author":"Ager","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0800","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/21681805.2020.1776767","article-title":"DaPeCa-4: outcome in penile cancer patients with N3 disease due to extra nodal extension treated with surgery and chemo-irradiation","volume":"54","author":"Maibom","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0805","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0810","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/bju.12946","article-title":"Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy","volume":"117","author":"Dickstein","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0815","doi-asserted-by":"crossref","first-page":"496.e17","DOI":"10.1016\/j.urolonc.2015.05.008","article-title":"Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study","volume":"33","author":"Sharma","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0820","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","article-title":"Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches","volume":"27","author":"Udager","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0825","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.3390\/jcm9103334","article-title":"The immune microenvironment in penile cancer and rationale for immunotherapy","volume":"9","author":"Ahmed","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.fjurol.2024.102736_bib0830","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/jnci\/djad155","article-title":"Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors","volume":"115","author":"El Zarif","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fjurol.2024.102736_bib0835","doi-asserted-by":"crossref","first-page":"S720","DOI":"10.1016\/j.annonc.2021.08.111","article-title":"715P Nivolumab in pretreated metastatic penile squamous cell carcinoma: Results of the penile cohort from the French AcS\u00e9 prospective program","volume":"32","author":"Pouessel","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0840","doi-asserted-by":"crossref","first-page":"eS16","DOI":"10.1016\/S0007-4551(20)30282-4","article-title":"Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE","volume":"107","author":"Gassian","year":"2020","journal-title":"Bull Cancer"},{"key":"10.1016\/j.fjurol.2024.102736_bib0845","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1158\/1078-0432.CCR-21-3726","article-title":"Cabozantinib plus nivolumab phase i expansion study in patients with metastatic urothelial carcinoma refractory to immune checkpoint inhibitor therapy","volume":"28","author":"Girardi","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.fjurol.2024.102736_bib0850","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1200\/JCO.2024.42.16_suppl.5009","article-title":"A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial","volume":"42","author":"Maluf","year":"2024","journal-title":"JCO"},{"key":"10.1016\/j.fjurol.2024.102736_bib0855","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1111\/j.1464-410X.2012.11437.x","article-title":"Dynamic sentinel node biopsy in penile cancer: initial experiences at a Swedish referral centre","volume":"111","author":"Kirrander","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0860","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eururo.2023.04.018","article-title":"Management of lymph node-positive penile cancer: a systematic review","volume":"85","author":"Sachdeva","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0865","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","article-title":"Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma","volume":"98","author":"Hakenberg","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0870","doi-asserted-by":"crossref","first-page":"E661","DOI":"10.1111\/j.1464-410X.2012.11453.x","article-title":"Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis","volume":"110","author":"Di Lorenzo","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0875","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fjurol.2024.102736_bib0880","doi-asserted-by":"crossref","first-page":"32212","DOI":"10.18632\/oncotarget.4802","article-title":"Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.fjurol.2024.102736_bib0885","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.eururo.2011.08.028","article-title":"Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study","volume":"60","author":"Di Lorenzo","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0890","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.juro.2013.12.038","article-title":"Penile sparing surgery for penile cancer-does it affect survival?","volume":"192","author":"Djajadiningrat","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0895","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.urology.2014.11.048","article-title":"Oncologic outcomes of penile cancer treatment at a UK supraregional center","volume":"85","author":"Veeratterapillay","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102736_bib0900","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jso.20980","article-title":"Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience","volume":"97","author":"Ornellas","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0905","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","article-title":"Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results","volume":"55","author":"Pizzocaro","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0910","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.urolonc.2017.07.025","article-title":"Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma","volume":"36","author":"Albersen","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0915","article-title":"Glansectomy and reconstruction for penile cancer: a systematic review","author":"Pang","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102736_bib0920","doi-asserted-by":"crossref","first-page":"838.e7","DOI":"10.1016\/j.urolonc.2021.08.028","article-title":"Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma","volume":"39","author":"Chakiryan","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0925","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2099::AID-CNCR20>3.0.CO;2-P","article-title":"Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma","volume":"77","author":"Lopes","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.fjurol.2024.102736_bib0930","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.urolonc.2013.11.008","article-title":"Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density","volume":"32","author":"Li","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0935","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s11255-021-02996-3","article-title":"The prognostic value of lymph node ratio in comparison to positive lymph node count in penile squamous cell carcinoma","volume":"53","author":"Yu","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0940","first-page":"7201","article-title":"Contemporary management of penile cancer: greater than 15 year MSKCC experience","volume":"21","author":"Moses","year":"2014","journal-title":"Can J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0945","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bju.13127","article-title":"DaPeCa-1: diagnostic accuracy of sentinel lymph node biopsy in 222 patients with penile cancer at four tertiary referral centres - a national study from Denmark","volume":"117","author":"Jakobsen","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib0950","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.urolonc.2012.01.017","article-title":"Clear-cell differentiation and lymphatic invasion, but not the revised TNM classification, predict lymph node metastases in pT1 penile cancer: a clinicopathologic study of 76 patients from a low incidence area","volume":"31","author":"Mannweiler","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0955","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00000478-199308000-00001","article-title":"Pathologic features of epidermoid carcinoma of the penis. A prospective study of 66 cases","volume":"17","author":"Cubilla","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0960","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/PAS.0b013e3181c7666e","article-title":"Papillary squamous cell carcinoma, not otherwise specified (NOS) of the penis: clinicopathologic features, differential diagnosis, and outcome of 35 cases","volume":"34","author":"Chaux","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0965","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-9-8","article-title":"Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer","volume":"9","author":"Maddineni","year":"2009","journal-title":"BMC Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0970","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.juro.2014.04.014","article-title":"Quality of life for patients treated for penile cancer","volume":"192","author":"Kieffer","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0975","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jsxm.2021.02.012","article-title":"Functional and patient reported outcomes following total glans resurfacing","volume":"18","author":"Preto","year":"2021","journal-title":"J Sex Med"},{"key":"10.1016\/j.fjurol.2024.102736_bib0980","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urology.2021.02.011","article-title":"Phallus preservation in penile cancer surgery: patient-reported aesthetic & functional outcomes","volume":"152","author":"Croghan","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102736_bib0985","doi-asserted-by":"crossref","first-page":"500.e9","DOI":"10.1016\/j.urolonc.2021.04.023","article-title":"Outcomes of perineal urethrostomy for penile cancer: a 20-year international multicenter experience","volume":"39","author":"de Vries","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102736_bib0990","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.brachy.2015.01.005","article-title":"Penile brachytherapy-Retrospective review of a single institution","volume":"14","author":"Pimenta","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.fjurol.2024.102736_bib0995","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.eururo.2007.10.028","article-title":"Treatment-seeking, aspects of sexual activity and life satisfaction in men with laser-treated penile carcinoma","volume":"54","author":"Skeppner","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib1000","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.juro.2016.12.089","article-title":"A prospective study of total glans resurfacing for localized penile cancer to maximize oncologic and functional outcomes in a tertiary referral network","volume":"197","author":"O\u2019Kelly","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib1005","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.juro.2014.04.083","article-title":"Glans preservation contributes to postoperative restoration of male sexual function: a multicenter clinical study of glans preserving surgery","volume":"192","author":"Yang","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib1010","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.urology.2005.06.081","article-title":"Sexual function after partial penectomy for penile cancer","volume":"66","author":"Romero","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102736_bib1015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0090-4295(97)00309-9","article-title":"Quality of life after partial penectomy for penile carcinoma","volume":"50","author":"D\u2019Ancona","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102736_bib1020","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1464-410X.2009.08424.x","article-title":"Total phallic reconstruction after penile amputation for carcinoma","volume":"104","author":"Garaffa","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib1025","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-022-04141-w","article-title":"Functional and surgical outcomes after phalloplasty in cis men","author":"Escoffier","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib1030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/SLA.0000000000002241","article-title":"Penis transplantation: first US experience","volume":"267","author":"Cetrulo","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.fjurol.2024.102736_bib1031","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bju.12878","article-title":"The treatment of penile carcinoma in situ (CIS) within a UK supra-regional network","volume":"115","author":"Lucky","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102736_bib1032","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.eururo.2008.01.019","article-title":"Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients","volume":"54","author":"Bandieramonte","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib1033","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.urology.2007.01.023","article-title":"Long-term follow-up after laser therapy for penile carcinoma","volume":"69","author":"Meijer","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102736_bib1034","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.juro.2017.10.045","article-title":"Penile Sparing Surgery for Penile Cancer: A Multicenter International Retrospective Cohort","volume":"199","author":"Baumgarten","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib1035","first-page":"153","article-title":"pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy","volume":"31","author":"Colecchia","year":"2009","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1016\/j.fjurol.2024.102736_bib1036","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.urology.2020.06.066","article-title":"Total Glans Resurfacing for the Management of Superficial Penile Cancer: A Retrospective Cohort Analysis in a Tertiary Referral Center","volume":"145","author":"Falcone","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102736_bib1037","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2010.09.039","article-title":"Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes","volume":"59","author":"Shabbir","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102736_bib1038","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2017.02.090","article-title":"Brachytherapy for Conservative Treatment of Invasive Penile Carcinoma: Prognostic Factors and Long-Term Analysis of Outcome","volume":"99","author":"Escande","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.fjurol.2024.102736_bib1039","first-page":"111","article-title":"PT2 penile squamous cell carcinomas (scc) - cavernosus vs. spongiosus invasion","volume":"7","author":"Rees","year":"2008","journal-title":"European Urology Supplements"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024001931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024001931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T04:00:33Z","timestamp":1732248033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393024001931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":112,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2950393024001931"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102736","relation":{},"ISSN":["2950-3930"],"issn-type":[{"value":"2950-3930","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French AFU Cancer Committee Guidelines\u2013Update 2024\u20132026: Penile cancer","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102736"}}